A study has identified a possible second-line treatment for melanoma patients.
Click here for original story, MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy
Source: ScienceDaily
A study has identified a possible second-line treatment for melanoma patients.
Click here for original story, MDM2 counteracts resistance to CDK4/6 inhibitors for melanoma therapy
Source: ScienceDaily